アイオワ州における非小細胞肺癌の臨床試験
アイオワ州内の拠点で、非小細胞肺癌に関する29件の研究が参加者を募集しています。
アイオワ州内の都市
公式研究テキスト（英語）
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- 他14件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT04267848Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- Physicians' Clinic of Iowa PC, Cedar Rapids
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07388524Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- 他11件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06498635Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- University of Iowa Health Care Cancer Services Quad Cities, Bettendorf
- University of Iowa Hospitals & Clinics, Iowa City
- University of Iowa Health Care, Mission Cancer + Blood, Waukee
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06881784A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Accellacare of McFarland, Ames
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06667076A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- Research Site, Des Moines
- Research Site, Waterloo
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06868277A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- Local Institution - 0065, Iowa City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT06618287Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Physicians Clinic of Iowa, Cedar Rapids
- Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06712316A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
- Mercy Medical Center, Cedar Rapids
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06875310Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- University of Iowa Hospital and Clinics, Iowa City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
- Research Site, Waterloo
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT06692738Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
- Clinical Study Site, Waukee
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT06767514A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- University of Iowa, Iowa City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07020117A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Mission Cancer + Blood - IMMC, Des Moines
- University of Iowa, Iowa City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06793215A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- University of Iowa Hospitals & Clinics PARENT, Iowa City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/26更新 · NCT06892548A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- University of Iowa, Iowa City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04895709A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- University of Iowa, Iowa City
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT05208762Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- 他7件
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/14更新 · NCT06686771Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Iowa Health Care, Iowa City
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/11更新 · NCT05283330KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- University of Iowa Hospitals & Clinics, Iowa City
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/08更新 · NCT06026410Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive
- Iowa Methodist Medical Center, Des Moines
- 他4件
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- McFarland Clinic - Trinity Cancer Center, Fort Dodge
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/06更新 · NCT06116682Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- 他7件
被験者募集中第2相
18 Minutes · 全性別 · 2026/05/05更新 · NCT06031688Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
- University of Iowa Hospitals and Clinics, Iowa City
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/05更新 · NCT04317534A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
- Mission Cancer + Blood - Mission Cancer Foundation, Des Moines
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/24更新 · NCT06010329Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
- Physicians' Clinic of Iowa PC, Cedar Rapids
- 他10件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204GEMINI-NSCLC: NSCLC Biomarker Study
- University of Iowa, Iowa City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/02/05更新 · NCT05236114SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Iowa City
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Test-retest Evaluation of [18F]F-AraG PET
- University of Iowa Hospitals and Clinics, Iowa City
被験者募集中第2相
18歳以上 · 全性別 · 2024/10/24更新 · NCT06084806ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。